18F-FDG PET early after radiotherapy in lymphoina patients

被引:12
作者
Castellucci, P
Zinzani, PL
Nanni, C
Farsad, M
Moretti, A
Alinari, L
Battista, G
Pettinato, C
Marengo, M
Boschi, S
Canini, R
Baccarani, M
Monetti, N
Fanti, S
机构
[1] Policlin S Orsola Malpigli, PET Unit, UO Med Nucl, I-40100 Bologna, Italy
[2] Policlin S Orsola Malpigli, Ist Ematol, I-40100 Bologna, Italy
[3] Policlin S Orsola Malpigli, Ist Radiol, I-40100 Bologna, Italy
[4] Policlin S Orsola Malpigli, UO Fis Sanitaria, I-40100 Bologna, Italy
关键词
lymphoma; F-18-FDG; PET; radiotherapy;
D O I
10.1089/1084978042484740
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to evaluate the rate of postactinic inflammatory alterations that could lead to false-positive results in FDG-PET images, in a group of lymphoma patients studied with positron emission tomography (PET) early after the end of radiation therapy. Materials and methods: Sixteen (16) consecutive patients were referred to our center for malignant lymphoma; 14 of 16 patients had a mediastinal bulky mass at diagnosis. Each patient underwent chemotherapy and then radiotherapy (RT): for clinical reasons, shortly after RT (range, 25-56 days; mean, 38.7 days) a FDG PET scan was required to evaluate the effect of therapy. We intravenously injected 370 MBq of F-18-FDG, and after 60-90 minutes we recorded images. Results: Despite a relatively short time after RT, there was no pathological tracer uptake in 13 of 16 patients. In 3 cases, a mild increase in FDG uptake was observed, but no findings which would lead to a false-positive diagnosis. In 2 of 3 cases, postactinic pneumopathy was diagnosed (PET scan performed 51 and 52 days after RT); while in I patient, soft-tissue inflammation was present (PET scan performed 42 days after RT). Conclusion: Our data indicates that the rate of postactinic PET inflammatory alterations in lymphoma patients is not very high and appear to be not strictly linked to the elapsed time since the end of RT treatment.
引用
收藏
页码:606 / 612
页数:7
相关论文
共 19 条
[1]  
Bartold SP, 1997, J NUCL MED, V38, P990
[2]   Challenging cases and diagnostic dilemmas - Case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease [J].
Bomanji, JB ;
Syed, R ;
Brock, C ;
Jankowska, P ;
Dogan, A ;
Costa, DC ;
Ell, PJ ;
Lee, SM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3347-3349
[3]   RESIDUAL MASS IN LYMPHOMA MAY NOT BE RESIDUAL DISEASE [J].
CANELLOS, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) :931-933
[4]  
Cohade C, 2003, J NUCL MED, V44, P170
[5]  
DELBEKE D, 2002, MOL IMAGING BIOL, V4, P104
[6]   Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region [J].
Hany, TF ;
Gharehpapagh, E ;
Kamel, EM ;
Buck, A ;
Himms-Hagen, J ;
von Schulthess, GK .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (10) :1393-1398
[7]  
Hoskin PJ, 2003, EUR J NUCL MED MOL I, V30, pS37, DOI 10.1007/s00259-003-1158-5
[8]  
Kostakoglu L, 2002, J NUCL MED, V43, P1018
[9]   Positron emission tomography in the management of lymphomas: a summary [J].
O'Doherty, M. J. ;
Hoskin, P. J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) :S128-S130
[10]  
Reinhardt MJ, 2003, ANTICANCER RES, V23, P2941